0.44
-0.0021(-0.48%)
Currency In USD
| Previous Close | 0.44 |
| Open | 0.45 |
| Day High | 0.45 |
| Day Low | 0.43 |
| 52-Week High | 3.04 |
| 52-Week Low | 0.28 |
| Volume | 583,148 |
| Average Volume | 847,772 |
| Market Cap | 19.57M |
| PE | -0.34 |
| EPS | -1.29 |
| Moving Average 50 Days | 0.48 |
| Moving Average 200 Days | 0.92 |
| Change | -0 |
If you invested $1000 in Harvard Bioscience, Inc. (HBIO) 10 years ago, it would be worth $96.81 as of September 15, 2025 at a share price of $0.44. Whereas If you bought $1000 worth of Harvard Bioscience, Inc. (HBIO) shares 5 years ago, it would be worth $136.92 as of September 15, 2025 at a share price of $0.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
GlobeNewswire Inc.
Sep 09, 2025 11:00 AM GMT
Veteran life sciences industry financing leader appointed as new Board memberHOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced the appointment of Ste
Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
GlobeNewswire Inc.
Aug 04, 2025 8:30 PM GMT
HOLLISTON, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2025, before the market opens on August 11, 2025, and will hold a conference call to disc
Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
GlobeNewswire Inc.
Jul 17, 2025 11:00 AM GMT
Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board membersQ2 ’25 revenue anticipated to be $20.4 million and Company reiterates previously announced Q2 ‘25 gross margin guidance HO